{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/45294"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/45294","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Mass spectrometry imaging using cytometry by time-of-flight strategies for brain tissues: a literature review","abstract":"Mass spectrometry (MS) as an analytical approach could provide comprehensive identification and quantitation of the biomolecules (proteins, peptides, nucleic acids, lipids) in a cell, tissue, or organism, from biomarker discovery to prediction of response to therapy or intervention. Inductively coupled plasma mass spectrometry (ICP-MS), can determine the elemental composition of materials and has been used for below ppt levels (ppq) and better in some cases (transuranics and non-metals) to detect metals and other elements in water, soil, and air or blood and urine samples. Mass cytometry is an implementation of ICP-MS to single-cell analysis; it is based on metal isotope-tagged antibodies to quantify these bioconjugates. Imaging mass cytometry (IMC), a commercially available immunohistochemistry laser ablation-inductively coupled plasma-time-of-flight-mass spectrometry (LA-ICP-TOF-MS) system, was designed for molecular biomarkers imaging in the tissue sections (e.g., brain) through metal-tagged antibodies (typically, lanthanides). This thesis highlights the contributions of ICP-TOF-MS-based approaches towards advanced developments of mass cytometry (CyTOF) and discusses its biomedical applications for investigating neurodegenerative diseases while comparing it to other imaging modalities such as PET, MRI, Allen brain, etc. In conclusion, CyTOF, as a high-dimensional imaging tool, provides information on many clinical applications, such as hematopoiesis, transplantation, cancer, and autoimmunity.","abstract_html":"Mass spectrometry (MS) as an analytical approach could provide comprehensive identification and quantitation of the biomolecules (proteins, peptides, nucleic acids, lipids) in a cell, tissue, or organism, from biomarker discovery to prediction of response to therapy or intervention. Inductively coupled plasma mass spectrometry (ICP-MS), can determine the elemental composition of materials and has been used for below ppt levels (ppq) and better in some cases (transuranics and non-metals) to detect metals and other elements in water, soil, and air or blood and urine samples. Mass cytometry is an implementation of ICP-MS to single-cell analysis; it is based on metal isotope-tagged antibodies to quantify these bioconjugates. Imaging mass cytometry (IMC), a commercially available immunohistochemistry laser ablation-inductively coupled plasma-time-of-flight-mass spectrometry (LA-ICP-TOF-MS) system, was designed for molecular biomarkers imaging in the tissue sections (e.g., brain) through metal-tagged antibodies (typically, lanthanides). This thesis highlights the contributions of ICP-TOF-MS-based approaches towards advanced developments of mass cytometry (CyTOF) and discusses its biomedical applications for investigating neurodegenerative diseases while comparing it to other imaging modalities such as PET, MRI, Allen brain, etc. In conclusion, CyTOF, as a high-dimensional imaging tool, provides information on many clinical applications, such as hematopoiesis, transplantation, cancer, and autoimmunity.","abstract_has_math":false,"creators":["Akbari, Behnaz"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Bioimaging","degree_department":null,"school":null,"contributors":[],"advisors":["Jara, Hernan","McLean, John","Costello, Catherine"],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022","date_published":"2022","updated_at":"2026-11-18T20:14:57Z","subjects":["Medicine","Brain tissues","CyTOF","Inductively coupled plasma mass spectrometry","Mass cytometry imaging","Mass spectrometry","Metal-isotope-tagged antibodies"],"languages":["en_US"],"rights":["Attribution 4.0 International"],"rights_urls":["http://creativecommons.org/licenses/by/4.0/"],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0003-4266-9936"],"render_values":[{"text":"0000-0003-4266-9936","href":"https://orcid.org/0000-0003-4266-9936","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/45294","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/45294","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F45294","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Jara, Hernan","McLean, John","Costello, Catherine"]},{"key":"dc:creator","label":"Author","values":["Akbari, Behnaz"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0003-4266-9936"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2022-11-02T17:24:54Z"]},{"key":"dc:date.issued","label":"Date","values":["2022"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2022-11-01T22:04:13Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Bioimaging"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medicine","Brain tissues","CyTOF","Inductively coupled plasma mass spectrometry","Mass cytometry imaging","Mass spectrometry","Metal-isotope-tagged antibodies"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/45294"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Mass spectrometry (MS) as an analytical approach could provide comprehensive identification and quantitation of the biomolecules (proteins, peptides, nucleic acids, lipids) in a cell, tissue, or organism, from biomarker discovery to prediction of response to therapy or intervention. Inductively coupled plasma mass spectrometry (ICP-MS), can determine the elemental composition of materials and has been used for below ppt levels (ppq) and better in some cases (transuranics and non-metals) to detect metals and other elements in water, soil, and air or blood and urine samples. Mass cytometry is an implementation of ICP-MS to single-cell analysis; it is based on metal isotope-tagged antibodies to quantify these bioconjugates. Imaging mass cytometry (IMC), a commercially available immunohistochemistry laser ablation-inductively coupled plasma-time-of-flight-mass spectrometry (LA-ICP-TOF-MS) system, was designed for molecular biomarkers imaging in the tissue sections (e.g., brain) through metal-tagged antibodies (typically, lanthanides). This thesis highlights the contributions of ICP-TOF-MS-based approaches towards advanced developments of mass cytometry (CyTOF) and discusses its biomedical applications for investigating neurodegenerative diseases while comparing it to other imaging modalities such as PET, MRI, Allen brain, etc. In conclusion, CyTOF, as a high-dimensional imaging tool, provides information on many clinical applications, such as hematopoiesis, transplantation, cancer, and autoimmunity."]},{"key":"dc:title","label":"Title","values":["Mass spectrometry imaging using cytometry by time-of-flight strategies for brain tissues: a literature review"]}]}],"canonical_facts":{"dc:contributor.advisor":["Jara, Hernan","McLean, John","Costello, Catherine"],"dc:creator":["Akbari, Behnaz"],"dc:date.accessioned":["2022-11-02T17:24:54Z"],"dc:date.issued":["2022"],"dc:date.updated":["2022-11-01T22:04:13Z"],"dc:description.abstract":["Mass spectrometry (MS) as an analytical approach could provide comprehensive identification and quantitation of the biomolecules (proteins, peptides, nucleic acids, lipids) in a cell, tissue, or organism, from biomarker discovery to prediction of response to therapy or intervention. Inductively coupled plasma mass spectrometry (ICP-MS), can determine the elemental composition of materials and has been used for below ppt levels (ppq) and better in some cases (transuranics and non-metals) to detect metals and other elements in water, soil, and air or blood and urine samples. Mass cytometry is an implementation of ICP-MS to single-cell analysis; it is based on metal isotope-tagged antibodies to quantify these bioconjugates. Imaging mass cytometry (IMC), a commercially available immunohistochemistry laser ablation-inductively coupled plasma-time-of-flight-mass spectrometry (LA-ICP-TOF-MS) system, was designed for molecular biomarkers imaging in the tissue sections (e.g., brain) through metal-tagged antibodies (typically, lanthanides). This thesis highlights the contributions of ICP-TOF-MS-based approaches towards advanced developments of mass cytometry (CyTOF) and discusses its biomedical applications for investigating neurodegenerative diseases while comparing it to other imaging modalities such as PET, MRI, Allen brain, etc. In conclusion, CyTOF, as a high-dimensional imaging tool, provides information on many clinical applications, such as hematopoiesis, transplantation, cancer, and autoimmunity."],"dc:identifier.orcid":["0000-0003-4266-9936"],"dc:identifier.uri":["https://hdl.handle.net/2144/45294"],"dc:language.iso":["en_US"],"dc:rights":["Attribution 4.0 International"],"dc:rights.uri":["http://creativecommons.org/licenses/by/4.0/"],"dc:subject":["Medicine","Brain tissues","CyTOF","Inductively coupled plasma mass spectrometry","Mass cytometry imaging","Mass spectrometry","Metal-isotope-tagged antibodies"],"dc:title":["Mass spectrometry imaging using cytometry by time-of-flight strategies for brain tissues: a literature review"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Bioimaging"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:14:57Z"}